参考文献

［1］SILVERBERG S J，SHANE E，JACOBS T P，et al.A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery［J］.N Engl J Med，1999，341（17）：1249-1255.

［2］PARKS J，COE F，FAVUS M.Hyperparathyroidism in nephrolithiasis［J］.Arch Intern Med，1980，140（11）：1479-1481.

［3］ALON U S，ZIMMERMAN H，ALON M.Evaluation and treatment of pediatric idiopathic urolithiasis-revisited［J］.Pediatric Nephrol，2004，19（5）：516-520.

［4］STAPLETON F B，ROY S R，NOE H N，et al.Hypercalciuria in children with hematuria［J］.N Engl J Med，1984，310（21）：1345-1348.

［5］COEF L，PARKS J H，MOORE E S.Familial idiopathic hypercalciuria［J］.N Engl J Med，1979，300（7）：337-340.

［6］DEVUYST O，PIRSON Y.Genetics of hypercalciuric stone forming diseases［J］.Kidney Int，2007，72（9）：1065-1072.

［7］WORCESTER E M，GILLEN D L，EVAN A P，et al.Evidence that postprandial reduction of renal calcium reabsorption mediates hypercalciuria of patients with calcium nephrolithiasis［J］.Am J Physiol-Renal Physiol，2007，292（1）：F66-F75.

［8］COEF L，FAVUS M J，CROCKETT T，et al.Effects of low-calcium diet on urine calcium excretion，parathyroid function and serum 1，25（OH）2D3 levels in patients with idiopathic hypercalciuria and in normal subjects［J］.Ame J Med，1982，72（1）：25-32.

［9］MELTON L J R，CROWSON C S，KHOSLA S，et al.Fracture risk among patients with urolithiasis：a population-based cohort study［J］.Kidney Int，1998，53（2）：459-464.

［10］CURHAN G C，WILLETT W C，RIMM E B，et al.A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones［J］.N Engl J Med，1993，328（12）：833-838.

［11］CURHAN G C，WILLETT W C，SPEIZER F E，et al.Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women［J］.Ann Intern Med，1997，126（7）：497-504.

［12］BORGHI L，SCHIANCHI T，MESCHI T，et al.Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria［J］.N Engl J Med，2002，346（2）：77-84.

［13］ASPLIN J R.Hyperoxaluric calcium nephrolithiasis［J］.Endocrinol Metab Clin North Am，2002，31（4）：927-949.

［14］TAYLOR E N，CURHAN G C.Oxalate intake and the risk for nephrolithiasis［J］.J Am Soc Nephrol，2007，18（7）：2198-2204.

［15］GOLDFARB D S.Microorganisms and calcium oxalate stone disease［J］.Nephron.Physiol，2004，98（2）：48-54.

［16］MILLINER D S.The primary hyperoxalurias：an algorithm for diagnosis［J］.Am J Nephrol，2005，25（2）：154-160.

［17］LIESKE J C，MONICO C G，HOLMES W S，et al.International registry for primary hyperoxaluria［J］.Am J Nephrol，2005，25（3）：290-296.

［18］WORCESTER E M.Stones from bowel disease［J］.Endocrinol Metab Clin North Am，2002，31（4）：979-999.

［19］ASPLIN J R，COE F L.Hyperoxaluria in kidney stone formers treated with modern bariatric surgery［J］.J Urol，2007，177（2）：565-569.

［20］PARKS J H，WORCESTER E M，O’CONNOR R C，et al.Urine stone risk factors in nephrolithiasis patients with and without bowel disease［J］.Kidney Int，2003，63（1）：255-265.

［21］PAK C Y C，SAKHAEE K，MOE O，et al.Biochemical profile of stone-forming patients with diabetes mellitus［J］.Urology，2003，61（3）：523-527.

［22］EKERUO W O，TAN Y H，YOUNG M D，et al.Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients［J］.J Urol，2004，172（1）：159-163.

［23］ABATE N，CHANDALIA M，CABO-CHAN A V J，et al.The metabolic syndrome and uric acid nephrolithiasis：novel features of renal manifestation of insulin resistance［J］.Kidney Int，2004，65（2）：386-392.

［24］SAKHAEE K，ADAMS-HUET B，MOE O W，et al.Pathophysiologic basis for normouricosuric uric acid nephrolithiasis［J］.Kidney Int，2002，62（3）：971-979.

［25］PAK C Y C，POINDEXTER J R，PETERSON R D，et al.Biochemical distinction between hyperuricosuric calcium urolithiasis and gouty diathesis［J］.Urology，2002，60（5）：789-794.

［26］ETTINGER B，TANG A，CITRON J T，et al.Randomized trial of allopurinol in the prevention of calcium oxalate calculi［J］.N Engl J Med，1986，315（22）：1386-1389.

［27］WORCESTER E M，COE F L，EVAN A P，et al.Reduced renal function and benefits of treatment in cystinuria vs other forms of nephrolithiasis［J］.BJU Int，2006，97（6）：1285-1290.

［28］EVAN A P，COE F L，LINGEMAN J E，et al.Renal crystal deposits and histopathology in patients with cystine stones［J］.Kidney Int，2006，69（12）：2227-2235.

［29］NAKAGAWA Y，ASPLIN J R，GOLDFARB D S，et al.Clinical use of cystine supersaturation measurements［J］.J Urol，2000，164（5）：1481-1485.

［30］PAK C Y，FULLER C，SAKHAEE K，et al.Management of cystine nephrolithiasis with alphamercaptopropionylglycine［J］.J Urol，1986，136（5）：1003-1008.

［31］GOLDFARB D S，COE F L，ASPLIN J R.Urinary cystine excretion and capacity in patients with cystinuria［J］.Kidney Int，2006，69（6）：1041-1047.

［32］NICAR M J，HILL K，PAK C Y.Inhibition by citrate of spontaneous precipitation of calcium oxalate in vitro［J］.J Bone Miner Res，1987，2（3）：215-220.

［33］MOE O W，PREISIG P A.Dual role of citrate in mammalian urine［J］.Curr Opin Nephrol Hypertens，2006，15（4）：419-424.

［34］LEMANN J J，PLEUSS J A，GRAY R W，et al.Potassium administration reduces and potassium deprivation increases urinary calcium excretion in healthy adults［corrected］［J］.Kidney Int，1991，39（5）：973-983.

［35］BARCELO P，WUHL O，SERVITGE E，et al.Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis［J］.J Urol，1993，150（6）：1761-1764.

［36］ETTINGER B，PAK C Y，CITRON J T，et al.Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis［J］.J Urol，1997，158（6）：2069-2073.

［37］HOFBAUER J，HÖBARTH K，SZABO N，et al.Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate urolithiasis-a prospective randomized study［J］.Br J Urol，1994，73（4）：362-365.

［38］COE F L，EVAN A，WORCESTER E.Pathophysiology-based treatment of idiopathic calcium kidney stones［J］.Clin J Am Soc Nephrol，2011，6（8）：2083-2092.

［39］SELTZER M A，LOW R K，MCDONALD M，et al.Dietary manipulation with lemonade to treat hypocitraturic calcium nephrolithiasis［J］.J Urol，1996，156（3）：907-909.

［40］PENNISTON K L，STEELE T H，NAKADA S Y.Lemonade therapy increases urinary citrate and urine volumes in patients with recurrent calcium oxalate stone formation［J］.Urology，2007，70（5）：856-860.

［41］KALE S S，GHOLE V S，PAWAR N J，et al.Inter-annual variability of urolithiasis epidemic from semi-arid part of Deccan Volcanic Province，India：climatic and hydrogeochemical perspectives［J］.Int J Environ Health Res，2014，24（3）：278-289.

［42］ALATAB S，POURMAND G，EL HOWAIRIS M E F，et al.National profiles of urinary calculi：a comparison between developing and developed worlds［J］.Iran J Kidney Dis，2016，10（2）：51-61.

［43］VINAROVA L，VINAROV Z，TCHOLAKOVA S，et al.The mechanism of lowering cholesterol absorption by calcium studied by using an in vitro digestion model［J］.Food Funct，2016，7（1）：151-163.

［44］GUASCH-FERRÉ M，BULLÓ M，BABIO N，et al.Mediterranean diet and risk of hyperuricemia in elderly participants at high cardiovascular risk［J］.J Gerontol A Biol Sci Med Sci，2013，68（10）：1263-1270.

［45］THALUT K，RIZAL A，BROCKIS J G，et al.The endemic bladder stones of Indonesia-epidemiology and clinical features［J］.Br J Urol，1976，48（7）：617-621.

［46］YASUI T，IGUCHI M，SUZUKI S，et al.Prevalence and epidemiological characteristics of urolithiasis in Japan：national trends between 1965 and 2005［J］.Urology，2008，71（2）：209-213.

［47］SRIBOONLUE P，PRASONGWATANA V，CHATA K，et al.Prevalence of upper urinary tract stone disease in a rural community of north-eastern Thailand［J］.Br J Urol，1992，69（3）：240-244.

［48］AFAJ A H，SULTAN M A.Mineralogical composition of the urinary stones from different provinces in Iraq［J］.Sci World J，2005，5：24-38.

［49］IGUCHI M，UMEKAWA T，KATOH Y，et al.Prevalence of urolithiasis in Kaizuka City，Japan-an epidemiologic study of urinary stones［J］.Int J Urol，1996，3（3）：175-179.

［50］SALEM S N，ABU ELEZZ L Z.The incidence of renal colic and calculi in Kuwait.An epidemiological study［J］.J Med Liban，1969，22（6）：747-755.

［51］ZENG Q，HE Y.Age-specific prevalence of kidney stones in Chinese urban inhabitants［J］.Urolithiasis，2013，41（3）：91-93.